Parathyroid Hormone, CAP
0095611
Ordering Recommendation
 
Mnemonic
CAP
Methodology
Immunoradiometry
Performed
Varies
Reported
4-7 days  
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
Patient Preparation
  
Collect
Lavender (EDTA).  
Specimen Preparation
Separate plasma from cells within one hour of collection. Transfer 2 mL plasma to an ARUP Standard Transport Tube and freeze immediately. (Min: 1 mL)  
Storage/Transport Temperature
CRITICAL FROZEN. Separate specimens must be submitted when multiple tests are ordered.  
Unacceptable Conditions
Thawed specimens. Specimens not collected in lavender (EDTA). Specimens not frozen within one hour of collection.  
Remarks
  
Stability
Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 1 year  
Reference Interval
By report  
Interpretive Data
This test provides a quantitative determination ofCyclase Activating PTH (CAP) or whole parathyroid hormone (PTH 1-84) and total immunoreactive intact PTH (Total Intact PTH) to aid in the diagnosis of parathyroid disease. 1-84 PTH binds to the PTH/PTHrp receptor and operates through the adenylate cyclase stimulating pathway.  
Note
 
CPT Code(s)
83970
Components
Component Test Code*Component Chart NameLOINC
0095611Parathyroid Hormone, CAP 
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Cyclase Activating Parathyroid Hormone

Performed at Scantibodies